Foundations Push for Drug Research

The Boston Globe: Drug makers turning to nonprofits for cash, 2008-Apr-7, by Todd Wallack

Overall, disease foundations invested roughly $75 million in the biotech industry last year, up from $7 million in 2000, according to CenterWatch Monthly, an industry publication."It's becoming a significant method of funding," said Robert Coughlin, president of the Massachusetts Biotechnology Council, which is brainstorming ways to help bring more foundations and biotech companies together.